Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru最新文献_第4页

Ascitic fluid amylase-to-serum amylase ratio to predict pancreatic duct leaks causing ascites. 腹水淀粉酶与血清淀粉酶比值预测引起腹水的胰管渗漏。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Reid Wasserman, Ahmed Ali Al Qaffas, Peter Darwin, Klaus Mönkemüller, Patrick Okolo, Paul Yeaton, Vivek Kesar, Varun Kesar

{"title":"Ascitic fluid amylase-to-serum amylase ratio to predict pancreatic duct leaks causing ascites.","authors":"Reid Wasserman, Ahmed Ali Al Qaffas, Peter Darwin, Klaus Mönkemüller, Patrick Okolo, Paul Yeaton, Vivek Kesar, Varun Kesar","doi":"","DOIUrl":"","url":null,"abstract":"Objectives: Pancreatic duct leaks can cause ascites, and fluid amylase can be used as a marker to suggest pancreatic duct leak; however, there is no reference parameter or cutoff value for diagnosis. We assessed whether a novel ratio of ascitic fluid to serum amylase can reliably predict pancreatic leaks and need for endoscopic retrograde cholangiopancreatography (ERCP).Materials and methods: Patients who had fluid amylase from ascitic fluid and serum amylase within one week of confirmed pancreatic leaks via ERCP were included along with appropriate medical and surgical controls.Results: A total of sixteen patients were included in the study group. The mean ascitic fluid amylase to serum amylase ratio in the study group was 243, and 0.3511, and 0.9406 for medical and surgical controls respectively. The cutoff ratio to predict pancreatic leaks was 6.89 with 100% sensitivity and specificity (p-value 0.0000000000001347).Conclusions: Patients with a fluid to serum amylase ratio of at least 6.89 should be considered high risk for pancreatic leak with consideration to proceed directly to ERCP.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 4","pages":"329-332"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Helicobacter pylori and its role in the pathogenesis of follicular gastritis: an overview. 幽门螺杆菌及其在滤泡性胃炎发病机制中的作用综述。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Yeison Carlosama-Rosero, Gonzalo Latorre, Arnoldo Riquelme, José Darío Portillo-Miño

引用次数: 0

[Management of gastric GIST removed through submucosal tunneling endoscopic resection and 5 year follow-up. Case report]. 胃粘膜下隧道内镜切除胃间质瘤的治疗及5年随访。病例报告)。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Juan Antonio Chirinos-Vega, Patricia Valera-Luján

引用次数: 0

[Acceptability and screening outcomes for hepatitis B, C and human inmunodeficiency virus using rapid diagnostic tests in patients undergoing outpatient endoscopy]. [在门诊内窥镜检查患者中使用快速诊断检测乙型肝炎、丙型肝炎和人类免疫缺陷病毒的可接受性和筛查结果]。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Ana Muñoz, Alberto Espino, Alejandro Soza, Alex Arenas, José Gran, Blanca Norero

{"title":"[Acceptability and screening outcomes for hepatitis B, C and human inmunodeficiency virus using rapid diagnostic tests in patients undergoing outpatient endoscopy].","authors":"Ana Muñoz, Alberto Espino, Alejandro Soza, Alex Arenas, José Gran, Blanca Norero","doi":"","DOIUrl":"","url":null,"abstract":"Introduction: Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections are a global public health concern. In 2019, there were 295.9 million people with chronic hepatitis B and 57.8 million with HCV, and less than 20% were aware of their status. In 2017, there were 37 million people with HIV, and 75% were diagnosed. Creating accessible screening strategies remains a challenge. The use of rapid diagnostic tests (RDTs) is a cost-effective and simple option. The endoscopy unit is an ideal setting due to its high patient flow and qualified personnel.Objective: To evaluate the use and acceptance of two RDTs for detecting HIV, HBV, and HCV in patients undergoing endoscopic examination and to determine the percentage of refusal to undergo testing.Materials and methods: An observational cross-sectional pilot study was conducted. Adults entering two Endoscopy Centers in Santiago were enrolled for outpatient endoscopic examination and were administered two RDTs: Montebio and HCV/HBsAg/HIV Rapid Test after counseling and informed consent.Results: 358 out of 375 patients (96%) accepted the test. 79% were female. The average age was 50±17 years. One subject tested positive for HCV in both tests (0.27%). There were no positive results for HBV/HIV. 17 patients (4.2%) declined the test. The refusal rate by gender was 8.8% (male) vs. 2.7% (female) (p=0.009). The overall experience was positive, and 98% would recommend the process.Conclusions: The use of RDTs in endoscopy represents an opportunity for systematic detection of infected patients with a high level of acceptance.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 4","pages":"354-358"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Treatment of Helicobacter pylori infection in the era of antibiotic resistance. What do we know?] 抗生素耐药时代幽门螺杆菌感染的治疗。我们知道什么？］

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Jorge Espinoza-Ríos

引用次数: 0

[Infrequent complications in a single patient: esophageal perforation, cervical vascular injury, and soft tissue infection caused by a spine]. 【单例罕见并发症：食道穿孔、颈椎血管损伤、脊柱引起的软组织感染】。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Hernando Marulanda Fernández, Juan Sebastián Frías Ordoñez, Zoraida Contreras, Jorge Peñafiel Ruiz, William Otero Regino

引用次数: 0

Ringed esophagus: all that glitters is not gold. 环形食道：闪光的未必都是金子。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Jeffrey Freidenson-Bejar, Alvaro Bellido-Caparó, Martin Tagle

引用次数: 0

[Assessment of corticosteroid use as a marker of quality-of-care in the management of inflammatory bowel disease]. [评估皮质类固醇使用作为炎症性肠病治疗质量的标志]。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Rodrigo Quera, Paulina Núñez F, Lilian Flores, Francisca Carvajal, Andrea Córdova, Camila Estay

{"title":"[Assessment of corticosteroid use as a marker of quality-of-care in the management of inflammatory bowel disease].","authors":"Rodrigo Quera, Paulina Núñez F, Lilian Flores, Francisca Carvajal, Andrea Córdova, Camila Estay","doi":"","DOIUrl":"","url":null,"abstract":"Introduction: Despite advancements in therapeutic strategies, corticosteroids continue to play a role in inducing remission in Inflammatory Bowel Disease (IBD). Unfortunately, these drugs are often misused.Objectives: To assess the dose and duration of corticosteroid therapy,and the subsequent change in treatment among patients with IBD.Materials and methods: We conducted a descriptive, retrospective observational study on patients with IBD under follow-up at the IBD Program of Clínica Universidad de los Andes from January 2021 to August2022.Results: Four hundred and thirty-two IBD were included, with 63% being women,with a median age of 42 years (14-94), 66% had ulcerative colitis (UC). Sixty-six percentageof patients had received corticosteroids during the course of their disease (range 1-9 times) for a median duration of 12 weeks (2-48 weeks), with prednisone being the most frequently used corticosteroids (53%). Seventy-seven percentage of patients had received treatment for over 3 months or in supratherapeutic doses (prednisone > 60 mg day). There was a change in the treatment after the use of corticosteroid in 28% of patients compared to 90% after entering the program (p<0.001, CI95%: 1.83-2.49). During the Program's follow-up, 10% received corticosteroids (71% prednisone, 29% budesonide) with no variations based on IBD type, gender, age, or treatment. No patient received corticosteroids for over 3 months or in supratherapeutic doses in our IBD Program.Conclusion: This study emphasizes the importanceof evaluating corticosteroids use as a quality-of -care marker in IBD. The management of these patients through a specialized program could mitigate the excessive use of these drugs.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 4","pages":"339-345"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Esophago-jejunal fistula closure using an over-the-scope clip: a case report]. 使用镜外夹闭合食管-空肠瘘1例。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

Lázaro Arango Molano, Andrés Sánchez Gil, Gian Núñez Rojas, Herney Solarte Pineda, Santiago Salazar Ochoa

{"title":"[Esophago-jejunal fistula closure using an over-the-scope clip: a case report].","authors":"Lázaro Arango Molano, Andrés Sánchez Gil, Gian Núñez Rojas, Herney Solarte Pineda, Santiago Salazar Ochoa","doi":"","DOIUrl":"","url":null,"abstract":"Esophago-jejunal anastomoses fistula could be mortal. Currently there is a wide therapeutic measure ranging from conservative management, endoscopic therapy and surgery. Endoscopic management has been positioned above other strategies due to minimal invasion which improves survival and reduces mortality. The endoscopic treatment of esophagojejunal fistulas can be varied with numerous techniques described to achieve their closure. These techniques include the placement of covered or partially covered self-expanding stents, the use of metal clips, alone or assisted by the loop technique, the use of endoscopic closed subatmospheric pressure therapy and, more recently, the use of endoscopic suture. In our service we use the techniques according to the characteristics of the fistula. In the case presented, it was decided, at the time of the endoscopy, to use clips with the help of a Cap to facilitate the technique and in the terminal closure angle, given the redundant tissue that was difficult to approach, we chose to place a clip Padlock®; With this, closure of the lesion was achieved in a few days with excellent clinical outcomes.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 4","pages":"406-410"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pancreatic adenocarcinoma during pregnancy. Case report. 妊娠期胰腺腺癌。病例报告。

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru Pub Date : 2024-10-01

César Vivian Lopes, César Al Alan Elias, Cláudio Mesquita Campello, Luis Felipe Carissimi Schmidt, Lucas Torelly Filippi, Eduardo Cambruzzi

{"title":"Pancreatic adenocarcinoma during pregnancy. Case report.","authors":"César Vivian Lopes, César Al Alan Elias, Cláudio Mesquita Campello, Luis Felipe Carissimi Schmidt, Lucas Torelly Filippi, Eduardo Cambruzzi","doi":"","DOIUrl":"","url":null,"abstract":"Pancreatic ductal adenocarcinoma during pregnancy is extremely rare. Overall, including our case, only 19 cases confirmed antepartum have been reported to date. We report the case of a 37 year-old woman at 24 weeks of pregnancy in whom a pancreatic adenocarcinoma was identified during investigation of a suspected acute pancreatitis. Surgery was postponed until fetal maturity. However, chemotherapy was not tolerated, clinical condition of the mother worsened after cesarean section, and surgical findings revealed an unresectable disease. Patient died due to septic shock and multiple organ failure, but her child is in very good health. Pancreatic ductal adenocarcinoma during pregnancy carries the same poor prognosis of the general population. A pregnant with severe epigastric pain radiating to the back, in the presence of jaundice and weight loss, should rule out a pancreatic neoplasm. In case a malignancy is identified, the histology diagnosis is required, and decisions should be taken as a consensus between the mother and a multidisciplinary team in a referal center.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"44 4","pages":"400-405"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0